Golden State Equity Partners »

Aerovate Therapeutics shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Golden State Equity Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $246k 11k 22.63
2023-09-30 $143k 11k 13.57
2023-06-30 $181k 11k 17.15
2023-03-31 $212k 11k 20.17
2022-03-31 $385k 21k 18.35
2021-12-31 $188k 16k 11.80

More positions owned by Golden State Equity Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
salesforce (CRM)
First Tr Mid Cap Core Alphad Com Shs (FNX)
JPMorgan Chase & Co. (JPM)
Hartford Fds Exchange Traded Total Rtrn Etf (HTRB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exch Traded Fd Iii Horizon Mngd Etf (HDMV)
First Tr Exch Traded Fd Iii Horizon Dmst Etf (HUSV)

View all positions for Golden State Equity Partners

Top funds holding Aerovate Therapeutics

RA Capital Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Cormorant Asset Management
Frazier Life Sciences Management
Dr. Jeffrey R. Jay, M.D.
OrbiMed Advisors
Vanguard Group
Point72 Asset Management
Octagon Capital Advisors
Paradigm Biocapital Advisors
Hudson Bay Capital Management
Nantahala Capital Management
Fred Alger Management
Charles Schwab Investment Management

View all funds holding Aerovate Therapeutics